JPH07509735A - 抗不整脈薬の放出制御用システム - Google Patents

抗不整脈薬の放出制御用システム

Info

Publication number
JPH07509735A
JPH07509735A JP6521208A JP52120894A JPH07509735A JP H07509735 A JPH07509735 A JP H07509735A JP 6521208 A JP6521208 A JP 6521208A JP 52120894 A JP52120894 A JP 52120894A JP H07509735 A JPH07509735 A JP H07509735A
Authority
JP
Japan
Prior art keywords
heart
control device
drug
rhythm control
antiarrhythmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6521208A
Other languages
English (en)
Japanese (ja)
Inventor
レヴィ，ロバート　ジェー．
シントヴ，アムノン
Original Assignee
ザ　ボード　オブ　リージェンツ　オブ　ザ　ユニヴァーシティ　オブ　ミシガン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ　ボード　オブ　リージェンツ　オブ　ザ　ユニヴァーシティ　オブ　ミシガン filed Critical ザ　ボード　オブ　リージェンツ　オブ　ザ　ユニヴァーシティ　オブ　ミシガン
Publication of JPH07509735A publication Critical patent/JPH07509735A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/3629—Heart stimulators in combination with non-electric therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39—Heart defibrillators
    • A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP6521208A 1993-03-15 1994-03-15 抗不整脈薬の放出制御用システム Pending JPH07509735A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US033,307 1987-04-02
US3330793A 1993-03-15 1993-03-15
PCT/US1994/002838 WO1994021237A1 (en) 1993-03-15 1994-03-15 System for controlled release of antiarrhythmic agents

Publications (1)

Publication Number Publication Date
JPH07509735A true JPH07509735A (ja) 1995-10-26

Family

ID=21869658

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6521208A Pending JPH07509735A (ja) 1993-03-15 1994-03-15 抗不整脈薬の放出制御用システム

Country Status (7)

Country Link
EP (1) EP0644756A4 (de)
JP (1) JPH07509735A (de)
KR (1) KR950702101A (de)
AU (1) AU6446794A (de)
CA (1) CA2135767A1 (de)
NZ (1) NZ263685A (de)
WO (1) WO1994021237A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007058190A1 (ja) * 2005-11-16 2007-05-24 Tokai University Educational System 薬剤放出制御組成物および薬剤放出性医療器具

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6322548B1 (en) 1995-05-10 2001-11-27 Eclipse Surgical Technologies Delivery catheter system for heart chamber
US6524298B1 (en) 1995-06-07 2003-02-25 Cardiogenesis Corporation Therapeutic and diagnostic agent delivery
US7031775B2 (en) 1997-11-07 2006-04-18 Medtronic, Inc. Method and system for myocardial infarction repair
US6775574B1 (en) * 1997-11-07 2004-08-10 Medtronic, Inc. Method and system for myocardial infarction repair
ES2169980B1 (es) 1999-12-17 2003-11-01 Lipotec Sa Microcapsulas para la liberacion prolongada de farmacos.
US6613025B1 (en) 2000-05-25 2003-09-02 Scimed Life Systems, Inc. Method and apparatus for diagnostic and therapeutic agent delivery
US6572534B1 (en) 2000-09-14 2003-06-03 Abiomed, Inc. System and method for implanting a cardiac wrap
US6846296B1 (en) 2000-09-14 2005-01-25 Abiomed, Inc. Apparatus and method for detachably securing a device to a natural heart
US6616596B1 (en) 2000-11-28 2003-09-09 Abiomed, Inc. Cardiac assistance systems having multiple layers of inflatable elements
US6602182B1 (en) 2000-11-28 2003-08-05 Abiomed, Inc. Cardiac assistance systems having multiple fluid plenums
US6547716B1 (en) 2000-11-28 2003-04-15 Abiomed, Inc. Passive cardiac restraint systems having multiple layers of inflatable elements
US6540659B1 (en) 2000-11-28 2003-04-01 Abiomed, Inc. Cardiac assistance systems having bi-directional pumping elements
DE60117857D1 (de) 2000-12-27 2006-05-04 Genzyme Corp Kontrollierte freisetzung von anti-arrhythmica aus einem biodegradierbaren hydrogel für die lokale anwendung am herzen
CA2440387A1 (en) * 2001-03-23 2002-10-03 Durect Corporation Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
US20020188327A1 (en) * 2001-04-26 2002-12-12 Chester Struble Drug delivery for treatment of cardiac arrhythmia
US6626821B1 (en) 2001-05-22 2003-09-30 Abiomed, Inc. Flow-balanced cardiac wrap
EP1451306A1 (de) * 2001-11-06 2004-09-01 Medtronic, Inc. Verfahren und system zur operativen versorgung nach myokardinfarkt
US6968226B2 (en) * 2002-01-30 2005-11-22 Medtronic, Inc. Method and system for terminating an atrial arrhythmia
AU2003248751A1 (en) * 2002-06-28 2004-01-19 Genzyme Corporation Controlled release of anti-arrhythmic agents
EP1551505B1 (de) * 2002-10-04 2010-02-24 Microchips, Inc. Medizinische vorrichtung zur gesteuerten arzneimittelverabreichung sowie herzüberwachung und/oder herzstimulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374669A (en) * 1975-05-09 1983-02-22 Mac Gregor David C Cardiovascular prosthetic devices and implants with porous systems
US4506680A (en) * 1983-03-17 1985-03-26 Medtronic, Inc. Drug dispensing body implantable lead
US5090422A (en) * 1990-04-19 1992-02-25 Cardiac Pacemakers, Inc. Implantable electrode pouch
US5087243A (en) * 1990-06-18 1992-02-11 Boaz Avitall Myocardial iontophoresis
US5154182A (en) * 1991-02-15 1992-10-13 Siemens Pacesetter, Inc. Drug or steroid releasing patch electrode for an implantable arrhythmia treatment system
EP0578748B1 (de) * 1991-04-05 1996-05-01 Medtronic, Inc. Erfassungssystem mit subkutanen mehrfachelektroden

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007058190A1 (ja) * 2005-11-16 2007-05-24 Tokai University Educational System 薬剤放出制御組成物および薬剤放出性医療器具
JP5153340B2 (ja) * 2005-11-16 2013-02-27 学校法人東海大学 薬剤放出制御組成物および薬剤放出性医療器具

Also Published As

Publication number Publication date
WO1994021237A1 (en) 1994-09-29
AU6446794A (en) 1994-10-11
NZ263685A (en) 1997-08-22
EP0644756A1 (de) 1995-03-29
KR950702101A (ko) 1995-06-19
EP0644756A4 (de) 1996-02-28
CA2135767A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
US5387419A (en) System for controlled release of antiarrhythmic agents
JPH07509735A (ja) 抗不整脈薬の放出制御用システム
US6168801B1 (en) Controlled release drug delivery
US6370427B1 (en) Method and apparatus for dual chamber bi-ventricular pacing and defibrillation
Winkle et al. Measurement of cardioversion/defibrillation thresholds in man by a truncated exponential waveform and an apical patch-superior vena caval spring electrode configuration.
JP5153340B2 (ja) 薬剤放出制御組成物および薬剤放出性医療器具
US20020035388A1 (en) Temporary medical electrical lead having biodegradable electrode mounting pad loaded with therapeutic drug
DE4435652A1 (de) Beschichtung für Biomaterial
US20100152531A1 (en) Implantable medical device for drug delivery and method of use
Labhasetwar et al. Iontophoresis for modulation of cardiac drug delivery in dogs.
EP0652017B2 (de) Beschichtung für Biomaterial
Labhasetwar et al. Epicardial administration of ibutilide from polyurethane matrices: effects on defibrillation threshold and electrophysiologic parameters
Ouyang et al. Ischemic ventricular fibrillation: the importance of being spontaneous
Bolderman et al. Atrium-targeted drug delivery through an amiodarone-eluting bilayered patch
WO2011031301A2 (en) Intrapericardial delivery of periostin
Jones et al. Effects of lidocaine and verapamil on defibrillation in humans
US11052173B2 (en) Conductive biomaterial for enhancement of conduction in vitro and in vivo
AU2018308734B2 (en) Conductive benzoic acid based polymer containing biomaterial for enhancement of tissue conduction in vitro and in vivo
TRAPPE et al. Clinical efficacy and safety of the new cardioverter defibrillator systems
TRAPPE et al. Initial experience with a new transvenous defibrillation system
Levy et al. Polymeric drug delivery systems for treatment of cardiovascular calcification, arrhythmias and restenosis
US20210268152A1 (en) Conductive membrane for heart conditions
REYNOLDS et al. Comparison of the arrhythmogenic effect of myocardial infarction in the cat and dog
Minghui et al. Tines made of degradable materials with decreasing removal forces: An option to facilitate passive-fixation leads extraction from the very beginning?
Donor Kasten G Wand Martin $7". Anesth Analg 64: 491, 1985. We investigated whether anesthetized dogs (n-6) could be resuscitated from massive cardiovascular toxic intrave-nous hupivacaine overdoses. Five mg/kg of bupivacaine was given into the right atrium over 10 sec every minute until